Clinical Trial Update: Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

View source ↗

Summary

This trial evaluates the MiniMed 780G advanced hybrid closed-loop insulin delivery system in newly diagnosed children and adolescents with Type 1 diabetes, comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin therapy (insulin)
• MiniMed 780G

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Diabetes Mellitus, Type I | Status: RECRUITING